Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Virginia
Children's Oncology Group
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
Children's Oncology Group
Columbia University
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
University of Michigan Rogel Cancer Center